BNT162b2 mRNA COVID-19 vaccine-induced chilblain-like lesions reinforces the hypothesis of their relationship with SARS-CoV-2

J Eur Acad Dermatol Venereol. 2021 Aug;35(8):e493-e494. doi: 10.1111/jdv.17320. Epub 2021 May 10.

Authors

V Piccolo¹, A Bassi², G Argenziano¹, C Mazzatenta², M Cutrone³, I Neri⁴, R Grimalt⁵, T Russo¹

Affiliations

¹ Dermatology Unit, University of Campania Luigi Vanvitelli, Naples, Italy.
² UO Dermatologia- Azienda USL Toscana Nordovest, Lucca, Italy.
³ Ambulatorio di Dermatologia Pediatrica, Ospedale dell'Angelo Venezia, Ospedale San Bortolo Vicenza, Venezia, Italy.
⁴ Division of Dermatology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.
⁵ Universitat Internacional de Catalunya, Barcelona, Spain.

No abstract available

Publication types

Letter

MeSH terms

BNT162 Vaccine
COVID-19 Vaccines
COVID-19*
Chilblains*
Humans
RNA, Messenger
SARS-CoV-2

Substances

COVID-19 Vaccines
RNA, Messenger
BNT162 Vaccine